Aspirin, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate Tablet, Effervescent
NDC Package 0280-1085-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Aspirin, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate tablets is a drug for further processing. This formulation utilizes a tablet, effervescent delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 0280-1085.

Identification & Billing

NDC Package Code
0280-1085-05
Package Description
1600 POUCH in 1 CASE / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code
0280-1085
11-Digit Billing Format
00280108505

Clinical Specifications

Proprietary Name
Aspirin, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate
Non-Proprietary Name
Aspirin, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate
Substance Name
Aspirin; Dextromethorphan Hydrobromide; Phenylephrine Bitartrate
Dosage Form
Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Bayer Healthcare Llc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
12-13-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0280-1085-05 identifies a specific commercial package of 1600 pouch in 1 case / 2 tablet, effervescent in 1 pouch of Aspirin, Dextromethorphan Hydrobromide, Phenylephrine Bitartrate (UNFINISHED drug), drug for further processing labeled by Bayer Healthcare Llc.. This tablet, effervescent is formulated for use and contains aspirin; dextromethorphan hydrobromide; phenylephrine bitartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on December 13, 2018. The current certification is valid through December 31, 2026.

How is this Bayer Healthcare Llc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280108505. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0280-1085-05
11-Digit CMS (5-4-2)
00280-1085-05

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.